Inventor

SOULA OLIVIER

FR33 patents

⚠️ This page may combine multiple inventors who share the name “SOULA OLIVIER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SOULA OLIVIER

ADOCIA

Highly concentrated aqueous protein solution with reduced viscosity

Rapid-acting insulin formulation comprising a substituted anionic compound

Injectable solution at pH7 comprising at least one basal insulin the pI of which is from 5.8 to 8.5, a prandial insulin and/or a gastrointestinal hormone, and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals

Injectable solution at pH 7 comprising at least one basal insulin the pI of which is from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals

Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound

Rapid-acting insulin formulation comprising a substituted anionic compound

Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acid

Rapid-acting insulin formulation comprising an oligosaccharide

Compositions in the form of an injectable aqueous solution comprising human glucagon and a statistical co-polyamino acid

Rapid-acting insulin composition comprising a substituted citrate

Complex consisted of a polysaccharide and an HBP

Injectable solution at pH 7 comprising at least one basal insulin the pi of which is between 5.8 and 8.5 and a substituted co-polyamino acid

Injectable solution at pH 7 comprising at least one basal insulin the pI of which is between 5.8 and 8.5 and a substituted co-polyamino acid

Injectable solution at pH 7 comprising at least one basal insulin the isoelectric point of which is between 5.8 and 8.5 and a hydrophobized anionic polymer

SOULA OLIVIER

Injectable solution at pH 7 comprising at least one basal insulin whose PI is between 5.8 and 8.5

Administration form of osteogenic protein complexes

Polyglutamic acids functionalised by histidine derivatives and hydrophobic groups and the uses thereof, in particular for therapeutic purposes

Fast-acting insulin formulation

CHARVET RICHARD

Anionic polysaccharides functionalized by a hydrophobic acid derivative

Functionalized oligosaccharides

Anionic polysaccharides functionalized by at least two hydrophobic groups carried by an at least trivalent spacer

MONSANTO TECHNOLOGY LLC

Process and compositions promoting biological effectiveness of exogenous chemical substances in plants

Guanidine derivative compounds

SOULA GERARD

Dextran functionalized by hydrophobic amino acids

Complexes between an amphiphilic polymer and an osteogenic protein belonging to the family of BMPs

BONNET-GONNET CECILE

Pharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applications

MONSANTO CO

Process and compositions promoting biological effectiveness of exogenous chemical substances in plants

FLAMEL IRELAND LTD

Pharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applications

POULIQUEN GAUTHIER

Pharmaceutical formulations for the prolonged release of active principle(s) and their applications

DAHRI-CORREIA LATIFA

Complex polymere amphiphile-PDGF

SOULA REMI

Polysaccharides comprising carboxyl functional groups substituted by a hydrophobic alcohol derivative

BRINKER RONALD J

N-phosphonomethylglycine guanidine derivative salts

FLAMEL TECH SA

Long-acting colloidal insulin formulation and its preparation